Treatment of Persistent Positive H. pylori Infection

Introduction to Treatment Guidelines

The American Gastroenterological Association recommends bismuth quadruple therapy for 14 days as the most effective empiric treatment for persistent H. pylori infection after failed first-line therapy, achieving 80-90% eradication rates even against antibiotic-resistant strains 1, 2, 3

Before prescribing salvage therapy, it is essential to identify the specific reasons for treatment failure, including reviewing prior antibiotic exposures thoroughly, assessing medication adherence, and verifying adequate acid suppression 1
The American Gastroenterological Association suggests reviewing prior antibiotic exposures to avoid using clarithromycin-based regimens if the patient has a history of macrolide use and to avoid levofloxacin-based regimens if there is prior fluoroquinolone exposure 1, 2, 3

The American Gastroenterological Association recommends bismuth quadruple therapy for 14 days as the preferred second-line option after first-line clarithromycin-based triple therapy failure, consisting of high-dose PPI, bismuth subsalicylate, metronidazole, and tetracycline 1, 2, 3
For patients with no prior fluoroquinolone exposure, levofloxacin triple therapy is an alternative second-line option, consisting of high-dose PPI, amoxicillin, and levofloxacin 1, 2, 3

The American Gastroenterological Association suggests using antibiotic susceptibility testing to guide further treatment whenever possible after two failed eradication attempts 1, 2, 3
Rifabutin triple therapy is a rescue option for patients with multiple treatment failures, consisting of rifabutin, amoxicillin, and high-dose PPI 1, 2, 3

The American Gastroenterological Association recommends always using high-dose PPI twice daily, with esomeprazole or rabeprazole 40 mg being the preferred options, and taking PPI 30 minutes before meals on an empty stomach without concomitant antacids 1, 2, 3, 4
A 14-day duration is mandatory for all regimens, as it improves eradication by approximately 5% compared to 7-10 day regimens 1, 2, 3, 4

For patients with penicillin allergy, bismuth quadruple therapy is the first choice, but consider penicillin allergy testing to delist the allergy and enable amoxicillin use 1, 2

The American Gastroenterological Association recommends confirming eradication with appropriate testing, such as urea breath test or monoclonal stool antigen test, at least 4 weeks after completion of therapy, and discontinuing PPI at least 2 weeks before testing 1, 2, 3, 4